Nunzia Pharmaceutical Company (NUNZ)

NUNZ Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Sep 30, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Selling, General & Admin	96.97	78.06	0.04	0.03	0.03	0.01
Operating Expenses	96.97	78.06	0.04	0.03	0.03	0.01
Operating Income	-96.97	-78.06	-0.04	-0.03	-0.03	-0.01
Interest Expense	-0	-0	-	-	-	-
Other Non Operating Income (Expenses)	-0.01	-	-100.98	-	-	-
EBT Excluding Unusual Items	-96.99	-78.06	-101.02	-0.03	-0.03	-0.01
Other Unusual Items	-	-	-	-	0.01	-
Pretax Income	-96.99	-78.06	-101.02	-0.03	-0.02	-0.01
Net Income	-96.99	-78.06	-101.02	-0.03	-0.02	-0.01
Net Income to Common	-96.99	-78.06	-101.02	-0.03	-0.02	-0.01
Shares Outstanding (Basic)	413	305	285	253	0	0
Shares Outstanding (Diluted)	413	305	285	253	0	0
Shares Change (YoY)	42.64%	7.19%	12.82%	1204081.77%	-	12.10%
EPS (Basic)	-0.23	-0.26	-0.35	-0.00	-0.89	-0.62
EPS (Diluted)	-0.23	-0.26	-0.35	-0.00	-0.89	-0.62
EBIT	-96.97	-78.06	-0.04	-0.03	-0.03	-0.01

Source: S&P Global Market Intelligence. Standard template. Financial Sources.